SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0001140361-18-018201
Filing Date
2018-04-11
Accepted
2018-04-11 17:07:07
Documents
16
Period of Report
2018-04-11
Effectiveness Date
2018-04-11

Document Format Files

Seq Description Document Type Size
1 DEF 14A s002183x1_def14a.htm DEF 14A 2135170
2 s002183x1_bargraph1.jpg GRAPHIC 218867
3 s002183x1_bargraph2.jpg GRAPHIC 163083
4 s002183x1_bargraph3.jpg GRAPHIC 153495
5 s002183x1_diagram1.jpg GRAPHIC 73274
6 s002183x1_pickup1.jpg GRAPHIC 66446
7 s002183x1_pickup2.jpg GRAPHIC 46194
8 s002183x1_pickup3.jpg GRAPHIC 33622
9 s002183x1_pickup4.jpg GRAPHIC 69794
10 s002183x1_pickup5.jpg GRAPHIC 38724
11 s002183x1_pickup6.jpg GRAPHIC 33240
12 s002183x1_pickup7.jpg GRAPHIC 36458
13 s002183x1_pickup8.jpg GRAPHIC 39068
14 s002183x1_pipeline1.jpg GRAPHIC 239086
15 s002183x1_proxycard1.jpg GRAPHIC 465046
16 s002183x1_proxycard2.jpg GRAPHIC 404607
  Complete submission text file 0001140361-18-018201.txt   4938763
Mailing Address 2855 GAZELLE COURT CARLSBAD CA 92010
Business Address 2855 GAZELLE COURT CARLSBAD CA 92010 7609319200
IONIS PHARMACEUTICALS INC (Filer) CIK: 0000874015 (see all company filings)

IRS No.: 330336973 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEF 14A | Act: 34 | File No.: 000-19125 | Film No.: 18750633
SIC: 2834 Pharmaceutical Preparations